Summary & Overview
CPT 81380: High-Resolution HLA Class I Molecular Typing
CPT code 81380 represents a high-resolution molecular assay for human leukocyte antigen (HLA) genes focused on a single Class I locus. This test is clinically important for organ and stem cell transplantation compatibility, donor matching, and detailed immunogenetic assessment. Accurate HLA typing at high resolution can influence transplant outcomes and patient selection for immunologically sensitive therapies, making it a nationally relevant laboratory service.
Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical purpose and laboratory setting for CPT code 81380, along with coverage and billing considerations relevant to major national payers. The publication summarizes common modifiers and administrative elements associated with laboratory molecular testing, highlights typical sites of service, and outlines what types of benchmarks and policy updates to expect in related payer guidance. Where specific input data is unavailable, the report notes that those items are not provided.
The content is organized to help billing managers, laboratory directors, and policy analysts understand service definition, payer relevance, and the administrative context for high-resolution HLA Class I molecular testing under CPT code 81380. Data not available in the input are identified as such.
Billing Code Overview
CPT code 81380 describes a high-resolution molecular test for human leukocyte antigen (HLA) genes, performed for one Class I locus. The procedure involves laboratory molecular techniques to determine HLA variants at high resolution for clinical purposes such as transplant compatibility and immunogenetic evaluation.
Service type: Clinical molecular laboratory testing (HLA typing, high-resolution)
Typical site of service: Clinical laboratory or hospital-based molecular diagnostics laboratory
Clinical & Coding Specifications
Clinical Context
A 32-year-old patient undergoing evaluation as a potential organ (kidney) or marrow transplant donor/recipient is referred for high-resolution human leukocyte antigen (HLA) typing of a single Class I locus. The specimen (blood or buccal swab) is collected in the outpatient phlebotomy lab or transplant clinic and routed to the molecular diagnostic laboratory. A clinical laboratory scientist performs a molecular assay (e.g., sequence-based typing or next-generation sequencing) to determine high-resolution alleles for the specified Class I locus (HLA-A, HLA-B, or HLA-C). Results are reviewed by the laboratory director and reported to the transplant team or ordering provider to inform donor-recipient matching, immunogenetic risk assessment, or immune compatibility decisions. Typical sites of service include hospital outpatient laboratory, independent clinical laboratory, or specialized transplant center laboratory.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the professional (interpretive) component of a divided lab service if applicable to the reporting laboratory. |
TC | Technical component | Use when billing only the technical component (assay performance) of the test performed by the laboratory. |